Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

HIV RT inhibitors available for licensing from NIH

Jan. 15, 1998

Progenics, Roche collaborate on next-generation anti-HIV agents

Jan. 15, 1998

Novartis discloses HIV protease inhibitors with excellent pharmacodynamic profile

Jan. 14, 1998

Novel AIDS therapy shows promise

Jan. 14, 1998

Ribozyme HIV gene therapy demonstrates potential in phase I/II

Jan. 13, 1998

Anti-HIV fusion inhibitor from Trimeris advances to phase II

Jan. 12, 1998

Japanese launch announced for HIV protease inhibitor

Jan. 12, 1998

New antiviral agents emerge from European research collaboration

Jan. 9, 1998

Second-generation CMV retinitis compound enters phase I/II

Jan. 9, 1998

New AIDS treatment candidates disclosed by Vertex

Jan. 8, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...